SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (923)8/31/1998 7:39:00 PM
From: BDR  Read Replies (3) of 1016
 
A pertinent quote from the SF Chronicle article you cited a few days ago:

''A lot of people listen to the Wall Street
hype. But with medical device stocks, the
truth lies with the opinions of the
clinicians,'' a buy-side analyst says.

I would agree. In my opinion the main reason VVUS is trading near $3 is not the management, not the blatant hype from mercenary analysts (though hype and poor management are a setup for disappointment), and it is definitely not the shorts. The main reason is the product. If you can't get an erection pay $23 and poke a stick in it. If that doesn't work, cinch it up with a rubber band and poke a stick in it and it will work less than 50% of the time. In the absence of other less costly, less invasive, less effective choices, there will be a market for this stuff. In the presence of less costly, less invasive and more effective choices (Viagra now, more to come) the market will consist of the small number of really motivated people who have failed the preferred choices. That is a small number, ergo a small price for this stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext